Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

DMAC DiaMedica Therapeutics Inc

3,04

-0,02 (-0,65%)

21 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more DiaMedica Therapeutics Charts.

DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more DiaMedica Therapeutics Charts.

News DiaMedica Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
Mittwoch 8 Mai 2024 (2 Wochen vor) • Business Wire

DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024
Donnerstag 2 Mai 2024 (3 Wochen vor) • Business Wire

DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
Mittwoch 17 April 2024 (1 Monat vor) • Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
Dienstag 19 März 2024 (2 Monate vor) • Business Wire

DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference
Montag 29 Januar 2024 (4 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 23 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 23 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
Montag 22 Januar 2024 (4 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 2 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 2 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere DiaMedica Therapeutics Inc News-Artikel

Deutsche Telekom (QX)

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen